Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.

Kaizer Chiefs have emerged as a frontrunner for Tau's signature, but why is he all of a sudden available? Let's delve and ...

Characterised by the abnormal accumulation of two proteins, amyloid beta and phosphorylated tau (pTau), AD progresses ...

Bafana Bafana star Percy Tau could be available for free at the end of the current season as Egyptian giants are to release ...

DEPTAC. Based on PROTACs, or protein-targeting chimeras, D20, a dephosphorylation-targeting chimera, delivers PP1 to tau. The C-terminal tail (gray) helps the construct enter cells. [Courtesy of Xiao ...

Many regulars of the West Side Nut Club Fall Festival have been wondering what happened to USI’s TKE booth, a longtime ...

Dementia doesn't just erode memory -- it also changes behavior and mental health. A study shows the brain's salience network and tau protein may be involved.

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia.

The findings indicate that early changes in brain activity—happening in parallel with Aβ and tau accumulation—can predict future cognitive decline. “This suggests that we may be able to detect ...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ...